Published in BMC Complement Altern Med on August 13, 2002
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol (2009) 2.84
The prevalence, patterns of usage and people's attitude towards complementary and alternative medicine (CAM) among the Indian community in Chatsworth, South Africa. BMC Complement Altern Med (2004) 1.96
Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv (2010) 1.78
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complement Altern Med (2007) 1.45
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist (2012) 1.34
Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer (2005) 1.33
The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. BMC Cancer (2006) 1.30
Polypharmacy in older adults with cancer. Oncologist (2010) 1.23
Chiropractic and CAM utilization: a descriptive review. Chiropr Osteopat (2007) 1.20
Complementary and alternative medicine use among adults in Enugu, Nigeria. BMC Complement Altern Med (2011) 1.06
Does trust in health care influence the use of complementary and alternative medicine by chronically ill people? BMC Public Health (2006) 1.02
Presenting the alternative: cancer and complementary and alternative medicine in the Canadian print media. Support Care Cancer (2007) 1.01
The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer (2005) 0.96
Use of Chinese medicine by cancer patients: a review of surveys. Chin Med (2011) 0.95
Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Support Care Cancer (2011) 0.92
Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors. J Womens Health (Larchmt) (2012) 0.91
Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use. Evid Based Complement Alternat Med (2013) 0.91
Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Alternat Med (2013) 0.90
A sociobehavioral wellness model of acupuncture use in the United States, 2007. J Altern Complement Med (2013) 0.89
Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients. J Oncol Pract (2007) 0.88
Predictors of yoga use among patients with breast cancer. Explore (NY) (2010) 0.85
Consumer empowerment in dermatology. Dermatol Clin (2009) 0.84
Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda. Eur J Cancer Care (Engl) (2014) 0.83
Complementary medicine use in patients with head and neck cancer in Ireland. Eur Arch Otorhinolaryngol (2010) 0.82
Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis. Breast Care (Basel) (2008) 0.80
Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer. Complement Ther Med (2012) 0.80
Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer. Support Care Cancer (2009) 0.79
Integrative oncology: a Canadian and international perspective. Curr Oncol (2008) 0.78
Use of Folk Therapy in Taiwan: A Nationwide Cross-Sectional Survey of Prevalence and Associated Factors. Evid Based Complement Alternat Med (2015) 0.78
Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2016) 0.77
Acupressure and anxiety in cancer patients. Iran Red Crescent Med J (2015) 0.77
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial. Evid Based Complement Alternat Med (2012) 0.77
Determination of parameters affecting the use of complementary and alternative medicine in cancer patients and detection of prevalence of use. Afr J Tradit Complement Altern Med (2011) 0.76
Sex Differences in the Use of Complementary and Alternative Medicine among Adults with Multiple Chronic Conditions. Evid Based Complement Alternat Med (2016) 0.75
Soliciting an herbal medicine and supplement use history at hospice admission. J Palliat Med (2010) 0.75
Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics. Integr Cancer Ther (2012) 0.75
Use of complementary and alternative medicines among Malaysian cancer patients: A descriptive study. J Tradit Complement Med (2015) 0.75
A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers. Nutr Cancer (2014) 0.75
Polypharmacy in the Geriatric Oncology Population. Curr Oncol Rep (2017) 0.75
Biologically based complementary and alternative medicine use among breast cancer survivors: relationship to dietary fat consumption and exercise. Support Care Cancer (2006) 0.75
Prevalence and Predictors of Herbal Medicine Use Among Adults in the United States. J Patient Exp (2017) 0.75
Spiritual Therapy in Coping with Cancer as a Complementary Medical Preventive Practice. J Cancer Prev (2017) 0.75
Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA (1998) 35.46
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol (2000) 5.48
Herbal medicines and perioperative care. JAMA (2001) 5.05
The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer (1998) 4.95
Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol (2000) 3.10
Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst (2000) 2.87
Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med (1998) 2.85
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet (2001) 2.41
Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) (1999) 2.37
Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) (2000) 2.32
The educational value of consumer-targeted prescription drug print advertising. J Fam Pract (2000) 2.08
Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol (2001) 1.69
Direct to consumer advertising of prescription drugs. An idea whose time should not come. BMJ (1999) 1.44
Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDS (2001) 1.44
The use of alternative therapies by patients with Parkinson's disease. Neurology (2001) 1.35
Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol (2000) 1.20
Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol (2000) 1.16
Use of alternative therapies in older outpatients in the United States and Japan: prevalence, reporting patterns, and perceived effectiveness. J Gerontol A Biol Sci Med Sci (2001) 1.01
Complementary and alternative therapies for treating multiple sclerosis symptoms: a systematic review. Complement Ther Med (2000) 0.94
Biopharmacologic and herbal therapies for cancer: research update from NCCAM. J Nutr (2001) 0.93
Herbals, cancer prevention and health. J Nutr (2001) 0.92
Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med (2011) 12.52
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05
Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med (2007) 9.88
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol (2008) 8.79
Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med (2005) 7.73
An open letter to The BMJ editors on qualitative research. BMJ (2016) 7.49
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med (2004) 6.86
Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med (2013) 6.07
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) (2012) 5.22
Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2011) 4.78
Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med (2012) 4.47
Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med (2008) 4.28
Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med (2003) 4.15
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. J Clin Oncol (2009) 3.80
Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2012) 3.74
Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2011) 3.58
New contract for general practitioners. BMJ (2003) 3.45
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med (2008) 3.34
The future of general internal medicine. Report and recommendations from the Society of General Internal Medicine (SGIM) Task Force on the Domain of General Internal Medicine. J Gen Intern Med (2004) 3.19
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology (2010) 3.12
A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) (2008) 2.94
Will this patient develop persistent disabling low back pain? JAMA (2010) 2.87
Clinical update: intravenous iron for anaemia. Lancet (2007) 2.84
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83
Self reported receipt of care consistent with 32 quality indicators: national population survey of adults aged 50 or more in England. BMJ (2008) 2.80
Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican College of Physicians. Ann Intern Med (2014) 2.75
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma. Cancer (2010) 2.73
High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med (2011) 2.70
Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 2.69
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2007) 2.69
Preferences for cardiopulmonary resuscitation among patients 80 years or older: the views of patients and their physicians. J Am Med Dir Assoc (2003) 2.59
Surrogate consent for living related organ donation. JAMA (2004) 2.57
A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol (2002) 2.54
Low back pain. J Orthop Sports Phys Ther (2012) 2.50
Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial. J Clin Oncol (2006) 2.48
Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med (2012) 2.47
Using existing systematic reviews in complex systematic reviews. Ann Intern Med (2008) 2.36
Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med (2011) 2.29
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J Clin Oncol (2002) 2.26
Crash and risky driving involvement among novice adolescent drivers and their parents. Am J Public Health (2011) 2.25
Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res (2007) 2.21
Variability in pharmacy interpretations of physician prescriptions. Med Care (2009) 2.18
The appropriateness method. Med Decis Making (2004) 2.17
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2013) 2.05
Expanding the Andersen model: the role of psychosocial factors in long-term care use. Health Serv Res (2002) 2.00
Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 1.98
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat (2010) 1.96
Assessing surrogates as trial endpoints using mixed models. Stat Med (2005) 1.94
Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 1.92
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol (2007) 1.92
Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol (2009) 1.89
The variability and quality of medication container labels. Arch Intern Med (2007) 1.83
Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc (2004) 1.82
The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization. Cancer Epidemiol Biomarkers Prev (2007) 1.80
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat (2004) 1.78
Differences in risk factors for recurrent versus incident preterm delivery. Am J Epidemiol (2015) 1.78
The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med (2010) 1.76
Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control (2003) 1.73
Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother (2007) 1.70
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2008) 1.65
The effects of payment method on clinical decision-making: physician responses to clinical scenarios. Med Care (2004) 1.65
Appropriateness criteria for coronary angiography in angina: reliability and validity. Ann Intern Med (2008) 1.64
Applying the Gelberg-Andersen behavioral model for vulnerable populations to health services utilization in homeless women. J Health Psychol (2007) 1.64
Systematic review: comparison of the quality of medical care in Veterans Affairs and non-Veterans Affairs settings. Med Care (2011) 1.63
Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implement Sci (2012) 1.59
Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol (2012) 1.57
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. Lancet Oncol (2012) 1.55
Veteran identity and race/ethnicity: influences on VA outpatient care utilization. Med Care (2002) 1.54
Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med (2008) 1.53
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. Clin Cancer Res (2009) 1.53
The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved (2005) 1.53
Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc (2007) 1.52
Development and validation of a novel patient educational booklet to enhance colonoscopy preparation. Am J Gastroenterol (2011) 1.52
Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab (2011) 1.50
The lack of social gradient of health behaviors and psychosocial factors in Northern Italy. Soz Praventivmed (2005) 1.50
Biofeedback interventions for gastrointestinal conditions: a systematic review. Altern Ther Health Med (2002) 1.48
Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2. Cancer Biother Radiopharm (2005) 1.48
Comparisons of quality of surgical care between the US Department of Veterans Affairs and the private sector. J Am Coll Surg (2010) 1.47
Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer. Cancer Biol Ther (2002) 1.43
Empirical evidence of an association between internal validity and effect size in randomized controlled trials of low-back pain. Spine (Phila Pa 1976) (2009) 1.42
Targeting of HER2 antigen for the treatment of disseminated peritoneal disease. Clin Cancer Res (2004) 1.37
Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment. Cancer (2010) 1.36
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci (2012) 1.34
Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease. Clin Cancer Res (2007) 1.34
How accessible is medical care for homeless women? Med Care (2002) 1.32
The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage (2006) 1.32
Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2009) 1.30
Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc (2009) 1.27
Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med (2013) 1.27
Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories. Stat Med (2003) 1.26
Do elevated gravitational-force events while driving predict crashes and near crashes? Am J Epidemiol (2012) 1.24
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med (2011) 1.23
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer. Oncologist (2011) 1.21
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol (2004) 1.21
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol (2004) 1.20